SPY4:XETRA:XETRA-SSgA SPDR S&P 400 US Mid Cap (EUR)

ETF | Others |

Last Closing

USD 86.75

Change

+1.05 (+1.23)%

Market Cap

USD 1.99B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.75 (+1.44%)

USD 501.76B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.25 (+1.48%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.37 (+1.36%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.38 (+1.35%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.34 (+1.38%)

USD 157.79B
8R80:XETRA Amundi Index Solutions - Amund..

+2.74 (+1.90%)

USD 101.19B
JARI:XETRA Amundi Index Solutions - Amund..

+0.84 (+1.80%)

USD 100.74B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.74 (+1.44%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

+0.59 (+0.61%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.46 (+0.63%)

USD 80.38B

ETFs Containing SPY4:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.27% 62% D 64% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.27% 61% D- 62% D
Trailing 12 Months  
Capital Gain 23.82% 69% C- 70% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 23.82% 69% C- 69% C-
Trailing 5 Years  
Capital Gain 72.74% 81% B- 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 72.74% 81% B- 78% C+
Average Annual (5 Year Horizon)  
Capital Gain 14.63% N/A N/A 83% B
Dividend Return 14.63% N/A N/A 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.90% N/A N/A 35% F
Risk Adjusted Return 77.38% N/A N/A 80% B-
Market Capitalization 1.99B 87% B+ 77% C+

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike